| Christine H Gosch, MD | |
|
2500 Bellvu Med Ctr Dr, Bellevue, NE 68123-1591 | |
| (402) 763-3035 | |
| (402) 763-3194 |
| Full Name | Christine H Gosch |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 31 Years |
| Location | 2500 Bellvu Med Ctr Dr, Bellevue, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114030012 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 29809 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cox Medical Center Branson | Branson, MO | Hospital |
| Cox Monett Hospital | Monett, MO | Hospital |
| Mercy Hospital Lebanon | Lebanon, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolyn Clark Fnp Llc | 9638480080 | 4 |
| Mercy Hospital Lebanon | 7214829019 | 25 |
| Ozarks Medical Center | 3870491863 | 142 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Mercy Hospital Cassville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285676932 PECOS PAC ID: 8820999139 Enrollment ID: O20040120000164 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Ozarks Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831115641 PECOS PAC ID: 3870491863 Enrollment ID: O20040211000422 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Texas County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790740363 PECOS PAC ID: 9436041696 Enrollment ID: O20040401000307 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Cox-monett Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669687125 PECOS PAC ID: 0345236667 Enrollment ID: O20040521000080 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Mercy Hospital Aurora |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467543090 PECOS PAC ID: 9436063211 Enrollment ID: O20040727000335 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Mercy Hospital Lebanon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447284898 PECOS PAC ID: 7214829019 Enrollment ID: O20040907000806 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Mercy Hospital Aurora |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1467543090 PECOS PAC ID: 9436063211 Enrollment ID: O20061104000261 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Mercy Hospital Cassville |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1285676932 PECOS PAC ID: 8820999139 Enrollment ID: O20100118000033 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Carolyn Clark Fnp Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134500739 PECOS PAC ID: 9638480080 Enrollment ID: O20150625001983 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Entity Name | Skaggs Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346602646 PECOS PAC ID: 5092624320 Enrollment ID: O20160517000289 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine H Gosch, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: () - | Christine H Gosch, MD 2500 Bellvu Med Ctr Dr, Bellevue, NE 68123-1591 Ph: (402) 763-3035 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Advancements in antiretroviral therapy (ART) have allowed people living with HIV/AIDS to maintain a quality of life similar to those without HIV infection.
Scientists have found that brain networks develop differently in males and females at puberty, with boys showing an increase in connectivity in certain brain areas, and girls showing a decrease in connectivity as puberty progresses.
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California.
Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.
› Verified 8 days ago
Dr. George Loring Pratt, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 13504 Tregaron Cir, Bellevue, NE 68123 Phone: 402-293-0036 Fax: 402-293-0097 | |
Weston Ross, D.O Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2500 Bellevue Medical Center Dr, Bellevue, NE 68123 Phone: 402-763-3035 | |
Dr. Dalton J Nelsen, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2500 Bellevue Medical Center Dr, Bellevue, NE 68123 Phone: 402-763-3035 |